Market Report, "NovaScan, LLC - Product Pipeline Analysis", Published
NovaScan, LLC (NovaScan), formerly known as EPET, LLC, is involved in developing technologies that measures electrical properties of the materials. The company is the exclusive licensee for patents related to the technology from WiSys, a division of the Wisconsin Alumni Research Foundation (WARF). It has developed two devices, an in-vivo (FastPath residual cancer probe) and ex-vivo (Electrical Mammogram) to detect breast cancer. FastPath Probe is a hand held device that is used by surgeons to detect malignant tissue left in...
View full press release